2.55
price down icon6.25%   -0.17
pre-market  Pre-mercato:  2.49   -0.06   -2.35%
loading

Anixa Biosciences Inc Azioni (ANIX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2026-01-31 2025-10-31 2025-07-31 2025-04-30 2025-01-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Research and Development
3.50%
1.102
1.142 1.055 1.322 1.552
Costs And Expenses
5.56%
2.716
2.876 2.436 3.003 3.386
Operating Income/Loss
5.56%
-2.716
-2.876 -2.436 -3.003 -3.386
Income/Loss From Continuing Operations Before Tax
5.03%
-2.585
-2.722 -2.28 -2.813 -3.213
Income/Loss From Continuing Operations After Tax
5.03%
-2.585
-2.722 -2.28 -2.813 -3.213
Net Income/Loss
5.03%
-2.585
-2.722 -2.28 -2.813 -3.213
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
25.93%
-0.02
-0.027 -0.022 -0.023 -0.029
Basic Average Shares
203.04%
33.24
-32.26 32.48 32.20 32.20
Diluted Average Shares
203.04%
33.24
-32.26 32.48 32.20 32.20
Basic Earnings Per Share
11.11%
-0.08
-0.09 -0.07 -0.09 -0.10
Diluted Earnings Per Share
11.11%
-0.08
-0.09 -0.07 -0.09 -0.10
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$99.12
price up icon 0.49%
$28.33
price up icon 1.76%
$48.57
price up icon 0.16%
$91.18
price up icon 1.97%
ONC ONC
$310.79
price up icon 0.76%
$162.43
price down icon 1.47%
Capitalizzazione:     |  Volume (24 ore):